Bristol-Myers Squibb Co
Change company Symbol lookup
Select an option...
BMY Bristol-Myers Squibb Co
AMTR ETRACS Alerian Midstream Energy Total Return Index ETN
INCAF Inca One Gold Corp
BCS Barclays PLC
MOR MorphoSys AG
GBNH Greenbrook TMS Inc
ASTL Algoma Steel Group Inc
REKR Rekor Systems Inc
PRDO Perdoceo Education Corp
SCCC Sachem Capital Corp
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. The Company’s pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company’s products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.

Closing Price
$76.84
Day's Change
-0.16 (-0.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
76.98
Day's Low
75.77
Volume
(Light)
Volume:
10,882,707

10-day average volume:
13,941,614
10,882,707
  • Prev Close
    77.00
  • Today's Open
    76.98
  • Day's Range
    75.77-76.98
  • Avg Vol (10-day)
    13.9M
  • Last (time)
    7:00p ET 07/01/22
  • Last (size)
    2
  • 52-Wk Range
    53.22 - 80.59
    LowHigh
  • (11/30/21 - 06/27/22)
    4.65%
  • 17.9%
  • Market Cap
    163.6B
  • Shares Outstanding
    2.1B
  • 2.82
  • 27.28x
  • $2.16/2.81%
  • Ex-dividend Date
    06/30/22
  • Dividend Pay Date
    08/01/22
  • 0.4
  • 75.97
  • (% of float 06/15/22)
    1.62

Latest News

July 01, 2022
4:41 pm ET
MarketWatch
June 30, 2022
4:41 pm ET
MarketWatch
June 29, 2022
4:41 pm ET
MarketWatch
June 28, 2022
4:41 pm ET
MarketWatch
June 27, 2022
4:41 pm ET
MarketWatch
June 24, 2022
7:05 pm ET
BusinessWire
4:41 pm ET
MarketWatch
12:52 pm ET
BusinessWire
12:51 pm ET
BusinessWire
June 23, 2022
4:41 pm ET
MarketWatch
10:55 am ET
PR Newswire
June 22, 2022
4:50 pm ET
Zacks
4:41 pm ET
MarketWatch
June 21, 2022
4:41 pm ET
MarketWatch
June 20, 2022
6:59 am ET
BusinessWire
June 17, 2022
4:41 pm ET
MarketWatch
7:33 am ET
MarketWatch
June 16, 2022
4:41 pm ET
MarketWatch
June 15, 2022
4:41 pm ET
MarketWatch
4:16 pm ET
BusinessWire
4:16 pm ET
BusinessWire
June 14, 2022
4:41 pm ET
MarketWatch
11:00 am ET
PR Newswire
June 13, 2022
4:41 pm ET
MarketWatch
June 10, 2022
4:41 pm ET
MarketWatch
June 09, 2022
4:41 pm ET
MarketWatch
June 08, 2022
4:41 pm ET
MarketWatch
10:30 am ET
Zacks
6:59 am ET
BusinessWire
June 07, 2022
4:41 pm ET
MarketWatch
6:59 am ET
BusinessWire
June 06, 2022
4:41 pm ET
MarketWatch
2:19 pm ET
Globe Newswire
9:06 am ET
Globe Newswire
7:04 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.